Do you want to know more about how #killifish research can advance our understanding of retinal diseases? Have a look at Sofia Manzo's exciting work! Sofia is PhD fellow of the MSCA-DN @progret2024.bsky.social
@cabd-upo-csic.bsky.social @jrmarmor.bsky.social
#killifish #retinaldisease #aging
🧬👌🧬

Congratulatory graphic for the four awardees recognized with the 2026 ARVO Foundation Early Career Clinician-Scientist Award. From left to right, they are from Aravind Eye Hospital, The Chinese University of Hong Kong, Seoul National University Hospital, and Moorfields Eye Hospital NHS Foundation Trust. The ARVO Foundation for Eye Research logo is displayed in the bottom right corner.

Congratulations to the 2026 @arvoinfo.bsky.social Foundation Early Career Clinician-Scientist Research Awardees — Giovanni Montesano; Richul Oh; Anran Ran and Ganesh Venkataraman. Read about their work using #AI/genetic analysis to combat #glaucoma and #RetinalDisease.
https://bit.ly/4kCl7q4

リジェネロン、アフリベルセプト8mgのRVO第3相最終64週結果など発表へ──ELARA試験で月1回投与の主要結果も提示予定 | STELLANEWS.LIFE STELLANEWS.LIFE（ステラニュース・ライフ）は、科学や技術、医薬品分野における最新の研究成果や発見 | STELLANEWS.LIFE（ステラニュース・ライフ）は、科学や技術、医薬品分野における最新の研究成果や発見

リジェネロン、アフリベルセプト8mgのRVO第3相最終64週結果など発表へ──ELARA試験で月1回投与の主要結果も提示予定
Regeneron to Present Final 64-Week Phase 3 QUASAR Results in RVO and Primary Data from Monthly Dosing ELARA Trial of Aflibercept 8 mg

stellanews.life/technology/8...

#RetinalDisease
#Aflibercept
#ClinicalTrials

Stem cell therapy for inherited retinal diseases: Trends and insights from 2000 to 2024
doi.org/10.1177/0963...
#eye #retinaldisease #stemcell
@SageJournals

Catch up on cutting-edge advances in imaging, diagnostic tools, and therapies in ophthalmology with free access to our coverage of the 2025 #EURETINA congress.

👉 buff.ly/GId9u6w

#EURETINA2025 #RetinalDisease

Delve into this international panel's consensus on ILM peeling extent, vital dye selection, face-down positioning requirements, tamponade options, and more.

👉 buff.ly/H5fafUv

#RetinalDisease #EyeSurgery

Belite plans filing for oral Stargardt drug after phase 3 win The first therapy for sight-robbing Stargardt disease could be on the way, as Belite Bio's tinlarebant hits the mark in a phase 3 trial.

#BeliteBio has said the results of the DRAGON trial of its oral therapy for sight-robbing disorder #Stargardtdisease type 1 (STGD1), tinlarebant, could support an FDA filing. #retinaldisease

pharmaphorum.com/news/belite-...

A night view from the 10th floor overlooking a harbor area in an area of high rise buildings. Round, Random spots of colored lights represent the artist’s visual interpretation of glare in dark lighting

“Room 1022 - Harbor View”

Oil on canvas

9/2025

#oilpainting
#retinaldisease
#prps1

🎉 Big congratulations to @karkam.bsky.social who has just been awarded the PRO RETINA Research Award 2025 for her latest paper in American Journal of Human Genetics!

#ResearchAward #AcademicBlueSky #Ophthalmology #MacularDystrophy #Lysosomes #RetinalDisease #VisionResearch #RareDiseases

2025 award recipient Ryo Terao, MD, PhD with ARVO Foundation Chair Rafal Farjo, PhD, FARVO

Know an early-career scientist whose discovery profoundly changed treatment of a #retinaldisease. Nominate them for the @arvoinfo.bsky.social Foundation Bert M. Glaser, MD Award for Innovative Research in #Retina. Submit by Oct. 1: https://bit.ly/47YVYS5

Flip through the pages of this month’s digital edition of Ophthalmology Management: digital.ophthalmologymanagement.com/publication/...

#retina #retinal #retinaldisease #homemonitoring #RemotePatientMonitoring #optogenetics #geographicatrophy #privateequity #ophthalmology #youngophthalmologists

Here’s a glimpse at what’s in our latest issue! Be sure to read the full issue here: digital.ophthalmologymanagement.com/publication/....

#retina #retinal #retinaldisease #homemonitoring #RemotePatientMonitoring #optogenetics #geographicatrophy #ophthalmology #youngophthalmologists

SpliceBio gathers $135m for eye disease gene therapies Spain's SpliceBio has raised $135m in financing that will help it move a gene-editing therapy for Stargardt disease through clinical testing.

Spanish biotech #SpliceBio has raised $135 million in #financing that will help it move a #geneediting therapy for an inherited #retinaldisease through clinical testing.

Photo of Yujiao Wang next to a microscope.

🧪 Read our interview with first-author, Yujiao Wang. Yujiao is a Lecturer and Ophthalmologist in Danian Chen's lab at West China Hospital, Sichuan University.
#AMD #retinaldisease

journals.biologists.com/dmm/article/17/11/dmm052...

Mice and rabbit insights into restoring sight Recent animal studies in Austria and the US have provided new insights into restoring sight and treating retinal problems and blindness.Researchers at Vienna University of Technology (TU Wien), studyi...

👁️ Recent #AnimalResearch has provided new insights into treating retinal problems & blindness.

👁️ @tuwien.bsky.social found that nerve cells in the retina can carry out different tasks for vision, while Mass Eye and Ear developed a therapy to treat #RetinalDisease.
www.eara.eu/post/mice-an...

Topics include:

🩺 #Hemochromatosis management
📈 #PolygenicRiskScores #PRS in diverse populations
🧬 #CRISPR treating #retinaldisease
👶 #Genome sequencing in #NICUs

…and so much more.

Two week warning ⚠️ the poster abstract deadline for our meeting on Macular Degeneration is just under two weeks away ... August 27th at 11:59pm MDT. Make sure to get those abstracts submitted at keysym.us/KSMacularDeg.... #KSMacularDegen25 #maculardegeneration #retinaldisease youtu.be/k-ITXot8dNM